INZOLEN Injektions-/Infusionslösung

Recall | Medicines | 18/08/2022

The marketing authorisation holder informed its customers on August 15, 2022 that increased cobalt concentrations were detected during the ongoing stability programme. For this reason, the batches mentioned are being recalled. The medicinal product is authorised in Germany and placed on the market in Austria under the Austrian Act on the Import of Medicinal Products.

Name of the medicinal product INZOLEN Injektions-/Infusionslösung
Marketing authorisation number(s) Deutschland: 6072873.00.00
Marketing authorisation holder Dr. Franz Köhler Chemie GmbH
Batch number(s) 2002151, 2002152, 2002716, 2002717, 2008451, 2008452, 2008551, 2008552, 2016151, 2016152, 2018851, 2018852, 2020916, 2020917, 2021051, 2021052, 2030116, 2030117, 2030851, 2030852, 2030951, 2030952, 2031551, 2031552
Classification of the recall2
Depth of recall Pharmacies
BASG reference number INS-640.001-3972
Email

Further inquiry note